Health behaviors of early-stage non-small cell lung cancer survivors

被引:23
|
作者
Krebs, Paul [1 ,2 ]
Coups, Elliot J. [3 ,4 ]
Feinstein, Marc B. [5 ]
Burkhalter, Jack E. [2 ]
Steingart, Richard M. [5 ]
Logue, Amy [6 ]
Park, Bernard J. [7 ]
Ostroff, Jamie S. [2 ]
机构
[1] NYU, Sch Med, Div Gen Internal Med, New York, NY 10010 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, New York, NY 10021 USA
[3] UMDNJ Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Med, New Brunswick, NJ USA
[4] UMDNJ Sch Publ Hlth, Dept Hlth Educ & Behav Sci, New Brunswick, NJ USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[7] Hackensack Univ, Med Ctr, Dept Thorac Surg, New York, NY USA
关键词
Health behavior; Cancer screening; Survivorship; Lung cancer; QUALITY-OF-LIFE; LONG-TERM SURVIVORS; 2ND PRIMARY CANCERS; UNITED-STATES; RISK; SMOKING; ASSOCIATIONS; CONSUMPTION; DIAGNOSIS; EXERCISE;
D O I
10.1007/s11764-011-0191-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Lung cancer survivors are at risk for cancer recurrence and other chronic illnesses related predominantly to prior tobacco use and older age. Optimal quality of post-treatment care requires greater knowledge of survivors' adherence to behavioral health recommendations. This study reports the rates of smoking, physical activity, alcohol use, cancer screenings, and routine primary care visits in non-small cell lung cancer (NSCLC) survivors. Methods Stage IA and IB NSCLC survivors (N = 183, mean age = 69.0 years) with no evidence of disease 1-6 years post-treatment completed standard survey items regarding health and cancer screening behaviors. Results Most survivors (83.5%) had a history of smoking, but 64.8% quit prior to diagnosis and only 5.5% continued to smoke. Alcohol intake recommendations were exceeded by 5.4% and 17.3% of men and women, respectively. In a typical week, 23.1% met physical activity guidelines. Regarding cancer screenings, 89.3% were adherent to colorectal cancer screening guidelines. Among women, 72.0% had a mammogram within the previous year and 81.5% had a pap test in the previous 3 years; among men, 86.7% had a prostate-specific antigen test in the previous year. Almost all (97.3%) had seen a primary care provider in the past year. Discussions/conclusions The majority of lung cancer survivors were adherent to health promotion recommendations, but few engaged in the recommended level of physical activity. Implications for cancer survivors Physical and pulmonary rehabilitation interventions may help lung cancer survivors maintain sufficient levels of physical activity, which can have numerous benefits for older adults.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 50 条
  • [41] Social determinants of health and variability in treatment for patients with early-stage non-small cell lung cancer
    Bryan, Molly Scannell
    Hu, Xiaohan
    Izano, Monika A.
    Mohammed, Hina
    Wicks, Marianna
    Brown, Thomas
    Simon, George
    Kaplan, Henry
    Berry, Anna
    JNCI CANCER SPECTRUM, 2025, 9 (02)
  • [42] Lung Tissue Transcriptome as Predictor of Recurrence in Early-stage Non-small Cell Lung Cancer
    Darawshy, F.
    Dolgalev, I.
    Wu, B. G.
    Li, Y.
    Kwok, B.
    Schluger, R.
    Sulaiman, I.
    Tsirigos, A.
    Moreira, A.
    Pass, H.
    Tsay, J. J.
    Segal, L. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [43] Discussion to: Comprehensive sampling of the lung microbiome in early-stage non-small cell lung cancer
    Reddy, Rishindra M.
    Yendamuri, Sai
    JTCVS OPEN, 2024, 17 : 269 - 270
  • [44] Review of Hypofractionated Small Volume Radiotherapy for Early-stage Non-small Cell Lung Cancer
    Brock, J.
    Ashley, S.
    Bedford, J.
    Nioutsikou, E.
    Partridge, M.
    Brada, M.
    CLINICAL ONCOLOGY, 2008, 20 (09) : 666 - 676
  • [45] Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer
    Nagasaka, Misako
    Gadgeel, Shirish M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (01) : 63 - 70
  • [46] Predictors and Outcomes of Limited Resection for Early-Stage Non-Small Cell Lung Cancer
    Billmeier, Sarah E.
    Ayanian, John Z.
    Zaslavsky, Alan M.
    Nerenz, David R.
    Jaklitsch, Michael T.
    Rogers, Selwyn O.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (21): : 1621 - 1629
  • [47] Genomic profiling and metastatic risk in early-stage non-small cell lung cancer
    Fick, Cameron N.
    Dunne, Elizabeth G.
    Lankadasari, Manendra B.
    Mastrogiacomo, Brooke
    Asao, Tetsuhiko
    Vanstraelen, Stijn
    Liu, Yuan
    Sanchez-Vega, Francisco
    Jones, David R.
    JTCVS OPEN, 2023, 16 : 9 - 16
  • [48] Surgery for elderly early-stage non-small cell lung cancer: less or more?
    Afonso, Margarida
    Branco, Carlos
    Alfaro, Tiago M.
    Pancas, Rita
    Bernardo, Joao
    Cordeiro, Carlos Robalo
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [49] Trends and Outcomes of Salvage Lobectomy for Early-stage Non-Small Cell Lung Cancer
    Afshari, Sam
    Anker, Christopher J.
    Kooperkamp, Hannah Z.
    Sprague, Brian L.
    Lester-Coll, Nataniel H.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (06): : 271 - 275
  • [50] International expert consensus on immunotherapy for early-stage non-small cell lung cancer
    Liang, Wenhua
    Cai, Kaican
    Cao, Qingdong
    Chen, Chun
    Chen, Haiquan
    Chen, Jun
    Chen, Ke-Neng
    Chen, Qixun
    Chu, Tianqing
    Dong, Yuchao
    Fan, Jiang
    Fang, Wentao
    Fu, Junke
    Fu, Xiangning
    Gao, Shugeng
    Ge, Di
    Geng, Guojun
    Geng, Qing
    He, Jie
    Hu, Jian
    Hu, Jie
    Hu, Wei-Dong
    Jiang, Feng
    Jiang, Tao
    Jiao, Wenjie
    Li, He-Cheng
    Li, Qiang
    Li, Shanqing
    Li, Shuben
    Li, Xiangnan
    Liao, Yong-De
    Liu, Changhong
    Liu, Hongxu
    Liu, Yang
    Lu, Zhuming
    Luo, Qingquan
    Ma, Haitao
    Pan, Xiaojie
    Qiao, Guibin
    Ren, Shengxiang
    Shen, Weiyu
    Song, Yong
    Sun, Daqiang
    Wang, Guangsuo
    Wang, Jie
    Wang, Mengzhao
    Wang, Qiwen
    Wang, Wen-Xiang
    Wei, Li
    Wu, Ming
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (09) : 1742 - 1762